Results 1 to 10 of about 6,712,945 (253)

Virus-like Particles: Measures and Biological Functions

open access: yesViruses, 2022
Virus-like particles resemble infectious virus particles in size, shape, and molecular composition; however, they fail to productively infect host cells.
Tara Bhat, Amy Cao, John Yin
doaj   +2 more sources

Programmable polymorphism of a virus-like particle [PDF]

open access: yesCommunications Materials, 2022
Virus-like particles are promising for drug delivery systems and vaccine development, but controlling their size and morphology is challenging. Here, amino acid sequences are inserted into MS2 bacteriophage virus-like particles, with their size and shape
Artur P. Biela   +4 more
doaj   +6 more sources

Vaccine potential of Nipah virus-like particles. [PDF]

open access: yesPLoS ONE, 2011
Nipah virus (NiV) was first recognized in 1998 in a zoonotic disease outbreak associated with highly lethal febrile encephalitis in humans and a predominantly respiratory disease in pigs.
Pramila Walpita   +4 more
doaj   +2 more sources

Virus-like particles as immunogens.

open access: yesTrends in Microbiology, 2003
Subunit vaccines based on recombinant proteins can suffer from poor immunogenicity owing to incorrect folding of the target protein or poor presentation to the immune system.
Roy, Polly, Noad, Rob
core   +3 more sources

Virus-Like Particles Assembled Using Respiratory Syncytial Virus Matrix Protein Elicit Protective Immunity in Mice

open access: yesInfection and Drug Resistance, 2023
Su-Hwa Lee,1,* Ki-Back Chu,2,* Min-Ju Kim,3 Fu-Shi Quan1,2 1Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul, Republic of Korea; 2Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical ...
Lee SH, Chu KB, Kim MJ, Quan FS
doaj   +1 more source

Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles

open access: yesViruses
Virus-like particles are a well-established platform for vaccines, although the molecular mechanisms that underlie the extraordinary potency of many virus-like particles in eliciting strong antibody responses remain incompletely understood. Here, we show
Alexander R. Meyer   +4 more
doaj   +2 more sources

Analysis of dynamics of human parvovirus B19 virus-like particles [PDF]

open access: yes, 2023
岩手大学博士(学術)原著論文 Ishida K, Noguchi T, Kimura S, Suzuki H, Ebina H, Morita E. Tracking of Human Parvovirus B19 Virus-Like Particles Using Short Peptide Tags Reveals a Membrane-Associated Extracellular Release of These Particles Journal of Virology 97(2 ...
石田, 幸太郎
core   +1 more source

Characterization of chikungunya virus-like particles. [PDF]

open access: yesPLoS ONE, 2014
Chikungunya virus (CHIKV) is becoming a global concern due to the increasing number of outbreaks throughout the world and the absence of any CHIKV-specific vaccine or treatment.
Nitchakarn Noranate   +5 more
doaj   +1 more source

Size-selective downstream processing of virus particles and non-enveloped virus-like particles

open access: yesFrontiers in Bioengineering and Biotechnology, 2023
Non-enveloped virus-like particles (VLPs) are versatile protein nanoparticles with great potential for biopharmaceutical applications. However, conventional protein downstream processing (DSP) and platform processes are often not easily applicable due to
Nils Hillebrandt, Jürgen Hubbuch
doaj   +1 more source

Zika virus like particles elicit protective antibodies in mice. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2018
Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness known as Zika fever. Since its recent emergence in 2014 in the American continent, ZIKV infection during pregnancy has been closely associated with a wide range of ...
Mauricio A Salvo   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy